Home    中文  
 
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited
Application progress of high-dose furmonertinib in NSCLC with drug-resistant EGFR mutation
Zeng Jiao, Ding Jianghua
Journal of International Oncology . 2026, (8): 491 -495 .  DOI: 10.3760/cma.j.cn371439-20250929-00079